Cargando…
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Background: SOX2 and SOX9 are commonly overexpressed in glioblastoma, and regulate the activity of glioma stem cells (GSCs). Their specific and overlapping roles in GSCs and glioma treatment remain unclear. Methods: SOX2 and SOX9 levels were examined in human biopsies. Gain and loss of function dete...
Autores principales: | Garros-Regulez, Laura, Aldaz, Paula, Arrizabalaga, Olatz, Moncho-Amor, Veronica, Carrasco-Garcia, Estefania, Manterola, Lorea, Moreno-Cugnon, Leire, Barrena, Cristina, Villanua, Jorge, Ruiz, Irune, Pollard, Steven, Lovell-Badge, Robin, Sampron, Nicolas, Garcia, Idoia, Matheu, Ander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898154/ https://www.ncbi.nlm.nih.gov/pubmed/26878385 http://dx.doi.org/10.1517/14728222.2016.1151002 |
Ejemplares similares
-
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016) -
Oncogenic activity of SOX1 in glioblastoma
por: Garcia, Idoia, et al.
Publicado: (2017) -
SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2016) -
PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2018) -
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
por: Arrizabalaga, Olatz, et al.
Publicado: (2017)